Skip to main content

Articles

Page 1 of 31

  1. Hypereosinophilic syndrome is a group of disorders characterized by organ dysfunction caused by hypereosinophilia, which frequently leads to thromboembolic complications with potentially fatal outcomes. Interl...

    Authors: Daiki Nagira, Satoshi Miyamoto, Taishiro Mizukoshi, Atsushi Yanagisawa, Atsushi Funauchi, Kensuke Kanaoka, Hanako Yoshimura, Tatsunori Jo, Masayoshi Higashiguchi, Yujiro Naito, Takayuki Shiroyama, Satoshi Tetsumoto, Haruhiko Hirata, Yoshito Takeda and Atsushi Kumanogoh
    Citation: Allergy, Asthma & Clinical Immunology 2025 21:23
  2. Perflutren lipid microsphere suspension, sold under the brand name Definity®, is a microbubble ultrasound contrast agent. The microspheres contain octafluoropropane (C3F8) gas encapsulated by an outer lipid shell...

    Authors: Chloe Wang, Jackie Campbell, Harriet Lea-Banks and Erika Lee
    Citation: Allergy, Asthma & Clinical Immunology 2025 21:22
  3. Hyper-IgE Syndrome, also known as Job’s syndrome, is a rare primary immunodeficiency disorder characterized by recurrent infections and elevated levels of immunoglobulin E. While respiratory and systemic manif...

    Authors: Mohammad Mahjoubi, Ronak Rashedi, Noosha Samieefar, Fahimeh Abdollahimajd and Nima Rezaei
    Citation: Allergy, Asthma & Clinical Immunology 2025 21:20
  4. Allogenic hematopoietic stem cell transplantation (HSCT) is the optimal treatment of hematologic diseases and various malignancies. Development of allergic disease in a transplant patient has been reported.

    Authors: Young-Hee Nam and Hyun Jung Jin
    Citation: Allergy, Asthma & Clinical Immunology 2025 21:18
  5. Severe asthma and moderate-to-severe atopic dermatitis can significantly impact the lives of children and adolescents. However, real-world data on pediatric patients’ perceptions of their medication are limited.

    Authors: Markus Herzig, Maike vom Hove, Astrid Bertsche, Tobias Lipek, Wieland Kiess, Thilo Bertsche, Freerk Prenzel and Martina Patrizia Neininger
    Citation: Allergy, Asthma & Clinical Immunology 2025 21:16
  6. Authors: Stephen D. Betschel, Teresa Caballero, Douglas H. Jones, Hilary J. Longhurst, Michael Manning, Sally van Kooten, Markus Heckmann, Sherry Danese, Ledia Goga and Autumn Ford Burnette
    Citation: Allergy, Asthma & Clinical Immunology 2025 21:15

    The original article was published in Allergy, Asthma & Clinical Immunology 2024 20:43

  7. Food insecurity is a growing concern, that is currently estimated to affect 1 in 4 Canadian children. Due to the additional effort required for management and the disproportionate cost of allergy friendly food...

    Authors: Zoe Harbottle, Jakob Pettersson, Michael A. Golding, Marina Jonsson, Leslie E. Roos and Jennifer L. P. Protudjer
    Citation: Allergy, Asthma & Clinical Immunology 2025 21:14
  8. Evidence linking hereditary angioedema (HAE) to the potential association of developing other comorbidities, and how it is affected by HAE treatment is needed. The objective of this study is to identify comorb...

    Authors: Paul K. Keith, Gina Lacuesta, Dawn Goodyear, Stephen D. Betschel, Belinda Yap, Marie-France Dansereau, Nataly Tanios, Rami El-Sayegh, Maye Machnouk, Hachem Mahfouz, Adriana Martin and Susan Waserman
    Citation: Allergy, Asthma & Clinical Immunology 2025 21:13
  9. Hereditary angioedema (HAE) is a rare, potentially life-threatening condition that requires accessible and reliable information. YouTube has emerged as a significant source of health-related content, offering ...

    Authors: Pelin Korkmaz, Ilkim Deniz Toprak, Zeynep Kilinc, Derya Unal, Semra Demir and Asli Gelincik
    Citation: Allergy, Asthma & Clinical Immunology 2025 21:12
  10. An epidemiological association among asthma, blood eosinophil level and chronic rhinosinusitis (CRS) is well established, but whether consistent genetic relationships exist, and whether this reflects a shared ...

    Authors: Xian Li, Jingyun Li, Siyao Xue, Yunbo Gao, Lianqi Wan, Chengshuo Wang, Yuan Zhang and Luo Zhang
    Citation: Allergy, Asthma & Clinical Immunology 2025 21:11
  11. The goal of on-demand treatment for hereditary angioedema attacks is to halt attack progression to minimize morbidity and mortality. Four on-demand treatments have been approved thus far (ecallantide, icatiban...

    Authors: H. Henry Li, Emel Aygören-Pürsün, Markus Magerl, Timothy J. Craig, Michael E. Manning, Noemi Hummel, Agnieszka Kopiec, Shuai Fu, James Morris, Alice Wang, Paul K. Audhya and Jonathan A. Bernstein
    Citation: Allergy, Asthma & Clinical Immunology 2025 21:10
  12. Food oral immunotherapy (OIT) is an option for the treatment of immunoglobin E (IgE)‐mediated food allergy that involves administering gradually increasing doses of an allergenic food over time (under medical ...

    Authors: Mary McHenry, Philippe Bégin, Edmond S. Chan, Meriem Latrous and Harold Kim
    Citation: Allergy, Asthma & Clinical Immunology 2025 20(Suppl 3):82

    This article is part of a Supplement: Volume 20 Supplement 3

  13. Contact allergens typically trigger localised reactions, but systemic Type I hypersensitivity from skin contact reactions are rare.

    Authors: Bronte Jeffrey, Logan Gardner, Michelle Le, Julie Frost and Ming Wei Lin
    Citation: Allergy, Asthma & Clinical Immunology 2025 21:9
  14. When a member of a family has been diagnosed with hereditary angioedema (HAE) before a child is born, the question of early diagnosis arises. Indeed, the first attacks may occur at birth. Early diagnosis is co...

    Authors: A. Bocquet, A. Pagnier, I. Boccon-Gibod, F. Defendi, C. Dumestre-Perard, G. Hardy and Laurence Bouillet
    Citation: Allergy, Asthma & Clinical Immunology 2025 21:8
  15. Asthma is one of the most common respiratory disorders in Canada, however, many Canadians with asthma remain poorly controlled. In most patients, control can be achieved through appropriate therapy, including:...

    Authors: Andrew O’Keefe, Lori Connors, Ling Ling and Harold Kim
    Citation: Allergy, Asthma & Clinical Immunology 2025 20(Suppl 3):81

    This article is part of a Supplement: Volume 20 Supplement 3

  16. Our previous 2007 study reported a 19.4% rate of biphasic anaphylaxis in Kingston, Ontario. Since then, few updates have been published regarding the etiology and risk factors of biphasic anaphylaxis. This stu...

    Authors: Anne K. Ellis, Lubnaa Hossenbaccus, Sophia Linton, Hannah Botting, Eman Badawod, Alyssa Burrows and Sarah Garvey
    Citation: Allergy, Asthma & Clinical Immunology 2025 21:7
  17. The field of medicine is constantly changing and, as healthcare providers, we are fortunate to be practicing in a time when patients are living longer and novel therapeutic options continue to evolve. However,...

    Authors: Persia Pourshahnazari, Stephen D. Betschel, Vy. H. D. Kim, Susan Waserman, Rongbo Zhu and Harold Kim
    Citation: Allergy, Asthma & Clinical Immunology 2025 20(Suppl 3):80

    This article is part of a Supplement: Volume 20 Supplement 3

  18. Drug allergy encompasses a spectrum of immunologically-mediated hypersensitivity reactions (HSRs) with varying mechanisms and clinical presentations. This type of adverse drug reaction (ADR) not only affects p...

    Authors: Samira Jeimy, Tiffany Wong, Moshe Ben-Shoshan, Ana Maria Copaescu, Ghislaine A. C. Isabwe and Anne K. Ellis
    Citation: Allergy, Asthma & Clinical Immunology 2025 20(Suppl 3):78

    This article is part of a Supplement: Volume 20 Supplement 3

  19. Until recently, immediate emergency department (ED) transfer after food-related anaphylactic reactions was recommended regardless of symptom resolution following use of an epinephrine autoinjector (EAI). We ev...

    Authors: Yiwei Yin, Moshe Ben Shoshan, Marcus Shaker, Matthew Greenhawt and Kate M. Johnson
    Citation: Allergy, Asthma & Clinical Immunology 2025 21:5
  20. The incidence of allergic diseases has been increasing in Japan. In particular, a serious decline in the age of onset of allergic rhinitis has been observed. Passive smoking from parental smoking has a signifi...

    Authors: Kenji Shigehara, Naomi Matsumoto, Mitsuru Tsuge, Kazuhiro Uda, Yukie Saito, Masato Yashiro, Takashi Yorifuji, Masanori Ikeda and Hirokazu Tsukahara
    Citation: Allergy, Asthma & Clinical Immunology 2025 21:4
  21. Nasal allergen provocation tests are an important part of the diagnostics of allergic diseases triggered by environmental factors. Recently, increased attention has been paid to the potential use of this metho...

    Authors: Edyta Krzych-Fałta, Andrzej Namysłowski, Sławomir Białek, Monika E. Czerwińska, Konrad Furmańczyk, Aleksandra Tylewicz, Adam Sybilski, Bolesław Samoliński and Oksana Wojas
    Citation: Allergy, Asthma & Clinical Immunology 2025 21:3
  22. Primary immunodeficiencies (PID), now often referred to as inborn errors of immunity (IEI), are a large heterogeneous group of disorders that result from deficiencies in immune system development and/or functi...

    Authors: Vy H. D. Kim, Julia E. M. Upton, Beata Derfalvi, Kyla J. Hildebrand and Christine McCusker
    Citation: Allergy, Asthma & Clinical Immunology 2025 20(Suppl 3):76

    This article is part of a Supplement: Volume 20 Supplement 3

  23. Immunoglobulin replacement therapy (IgRT) is the current standard of care for primary antibody deficiency patients (majority of all primary immunodeficiency (PID) diseases), with growing real-world evidence su...

    Authors: Rajiv Mallick, Noemi Hahn and Christopher Scalchunes
    Citation: Allergy, Asthma & Clinical Immunology 2025 21:2
  24. Food allergy is defined as an adverse immunologic response to a food. Immunoglobulin E (IgE)-mediated reactions to foods are associated with a broad range of signs and symptoms that may involve any of the foll...

    Authors: Philippe Bégin, Susan Waserman, Jennifer L. P. Protudjer, Samira Jeimy and Wade Watson
    Citation: Allergy, Asthma & Clinical Immunology 2024 20(Suppl 3):75

    This article is part of a Supplement: Volume 20 Supplement 3

  25. Allergic rhinitis (AR) is a common disorder that is strongly linked to asthma and conjunctivitis. Classic symptoms include nasal congestion, nasal itch, rhinorrhea and sneezing. A thorough history, physical ex...

    Authors: Lana Rosenfield, Paul K. Keith, Jaclyn Quirt, Peter Small and Anne K. Ellis
    Citation: Allergy, Asthma & Clinical Immunology 2024 20(Suppl 3):74

    This article is part of a Supplement: Volume 20 Supplement 3

  26. Many clinicians feel uncomfortable with de-labelling penicillin allergies despite ample safety data. Point of care tools effectively support providers with de-labelling. This study’s objective was to increase ...

    Authors: Sujen Saravanabavan, Patrick McKernan, Scott Cameron, Natasha Kwan, Kristopher T. Kang, Ashley Roberts, Roxane Carr, Raymond Mak, Chelsea Elwood, Vanessa Paquette, Rochelle Stimpson, Bethina Abrahams, Edmond S. Chan, Kathryn Slayter, Alicia Rahier, Irina Sainchuk…
    Citation: Allergy, Asthma & Clinical Immunology 2024 20:73
  27. Eosinophilic esophagitis (EoE) is an atopic condition of the esophagus that has become increasingly recognized. Diagnosis of the disorder is dependent on the patient’s clinical manifestations and must be confi...

    Authors: Stephanie C. Erdle, Stuart Carr, Edmond S. Chan, Kara Robertson and Wade Watson
    Citation: Allergy, Asthma & Clinical Immunology 2024 20(Suppl 3):72

    This article is part of a Supplement: Volume 20 Supplement 3

  28. Food allergy typically begins early in life and persists as a lifelong condition. Delayed introduction of allergenic foods followed by years of hesitancy to introduce these foods early may have contributed to ...

    Authors: Edmond S. Chan, Elissa M. Abrams, Douglas P Mack, Jennifer L.P. Protudjer and Wade Watson
    Citation: Allergy, Asthma & Clinical Immunology 2024 20(Suppl 3):71

    This article is part of a Supplement: Volume 20 Supplement 3

  29. Non-immunoglobulin E (IgE)-mediated food allergies are characterized by delayed gastrointestinal (GI) manifestations that occur after exposure to an inciting food protein; they include food protein-induced all...

    Authors: Victoria E. Cook, Lori A. Connors, Timothy K. Vander Leek and Wade Watson
    Citation: Allergy, Asthma & Clinical Immunology 2024 20(Suppl 3):70

    This article is part of a Supplement: Volume 20 Supplement 3

  30. The body has a collection of physical barriers to prevent infection, but once these are overcome, we rely on our immune systems to protect us against a wide variety of infections. The complex mechanisms throug...

    Authors: Jean S. Marshall, Julia E. M. Upton, Harissios Vliagoftis, Kyla J. Hildebrand, Adam Byrne and Wade Watson
    Citation: Allergy, Asthma & Clinical Immunology 2024 20(Suppl 3):69

    This article is part of a Supplement: Volume 20 Supplement 3

  31. Eosinophilic gastrointestinal diseases (EGIDs) are chronic immune-mediated inflammatory disorders characterized by gastrointestinal symptoms and eosinophilic inflammation in specific regions of the gastrointes...

    Authors: Tomohito Takeshige, Ryo Koyama, Hiroaki Motomura, Akifumi Okajima, Toshihiko Nishioki, Junko Watanabe, Toshifumi Yae, Kenji Kido and Kazuhisa Takahashi
    Citation: Allergy, Asthma & Clinical Immunology 2024 20:68
  32. Oral food challenge (OFC) is the gold standard for diagnosing food allergies (FAs) but carries the risk of anaphylactic reaction. Stepwise OFC, starting with a low dose of allergen and progressing to medium an...

    Authors: Mika Ogata, Jun Kido, Takanobu Yoshida, Natsuko Nishi, Sachiko Shimomura, Nami Hirai, Tomoyuki Mizukami, Masaaki Yanai and Kimitoshi Nakamura
    Citation: Allergy, Asthma & Clinical Immunology 2024 20:67
  33. Allergen immunotherapy (AIT) is a potentially disease-modifying therapy that is effective for the treatment of allergic rhinitis/conjunctivitis, allergic asthma and stinging insect hypersensitivity. The decisi...

    Authors: Jean-Nicolas Boursiquot, Rémi Gagnon, Jaclyn Quirt and Anne K. Ellis
    Citation: Allergy, Asthma & Clinical Immunology 2024 20(Suppl 3):66

    This article is part of a Supplement: Volume 20 Supplement 3

  34. Angioedema can occur in the absence of urticaria and can be broadly divided into three main categories: mast cell-mediated (e.g., histamine), non-mast-cell-mediated (bradykinin-induced) and idiopathic angioede...

    Authors: Gina Lacuesta, Stephen D. Betschel, Ellie Tsai and Harold Kim
    Citation: Allergy, Asthma & Clinical Immunology 2024 20(Suppl 3):65

    This article is part of a Supplement: Volume 20 Supplement 3

  35. Urticaria (hives) is a common disorder that may be associated with angioedema (swelling that occurs beneath the skin). It is generally classified as acute or chronic, and chronic urticaria is further classifie...

    Authors: Moshe Ben-Shoshan, Amin Kanani, Chrystyna Kalicinsky and Wade Watson
    Citation: Allergy, Asthma & Clinical Immunology 2024 20(Suppl 3):64

    This article is part of a Supplement: Volume 20 Supplement 3

  36. Atopic dermatitis (AD) is a common, chronic skin disorder that can significantly impact the quality of life (QoL) of affected individuals as well as their families. Although the pathogenesis of the disorder is...

    Authors: Stuart Carr, Rebecca Pratt, Fred White and Wade Watson
    Citation: Allergy, Asthma & Clinical Immunology 2024 20(Suppl 3):63

    This article is part of a Supplement: Volume 20 Supplement 3

  37. Anaphylaxis is an acute, potentially fatal systemic hypersensitivity reaction with varied mechanisms and clinical presentations. Although prompt recognition and treatment of anaphylaxis are imperative, both pa...

    Authors: Elissa M. Abrams, Waleed Alqurashi, David A. Fischer, Timothy K. Vander Leek and Anne K. Ellis
    Citation: Allergy, Asthma & Clinical Immunology 2024 20(Suppl 3):62

    This article is part of a Supplement: Volume 20 Supplement 3

  38. This position statement addresses the critical concerns and recommended practices surrounding the use of panel food testing for diagnosing food allergies. Food allergies are a significant public health concern...

    Authors: Abdulrahman Al Ghamdi, Elissa M. Abrams, Stuart Carr, Mariam A. Hanna, Sari M. Herman, Elana Lavine, Harold Kim, Timothy K. Vander Leek and Douglas P. Mack
    Citation: Allergy, Asthma & Clinical Immunology 2024 20:61
  39. Asthma is a chronic, heterogeneous disease characterized by airway inflammation. Asthma exacerbations significantly increase the disease burden, necessitating new therapeutic approaches. Emerging evidence sugg...

    Authors: Divya Balan, Tejaswini Baral, Mohan K. Manu, Aswini Kumar Mohapatra and Sonal Sekhar Miraj
    Citation: Allergy, Asthma & Clinical Immunology 2024 20:60
  40. The Zéro allergie research clinic (Saguenay, Canada) is a clinical and research initiative in oral immunotherapy (OIT) for managing IgE-mediated food allergy (FA). A total of 183 children with FA and 27 non-aller...

    Authors: Bénédicte L. Tremblay, Philippe Bégin, Frédérique Gagnon-Brassard, Anne-Marie Boucher-Lafleur, Marie-Ève Lavoie, Anne-Marie Madore, Sarah Lavoie, Cloé Rochefort-Beaudoin, Claudia Nuncio-Naud, Charles Morin, Guy Parizeault and Catherine Laprise
    Citation: Allergy, Asthma & Clinical Immunology 2024 20:59
  41. Rasburicase, a recombinant urate oxidase enzyme, has potent efficacy in controlling uric acid and is widely used to prevent tumor lysis syndrome in high-risk patients owing to its low toxicity profile. However...

    Authors: Yoshikazu Utsu, Natsuho Kaneda, Makio Kawakami, Shin-ichi Masuda, Hironori Arai, Sonoko Shimoji, Rena Matsumoto, Takafumi Tsushima, Kazusuke Tanaka, Kosuke Matsuo, Chiharu Kimeda, Shiho Konno and Nobuyuki Aotsuka
    Citation: Allergy, Asthma & Clinical Immunology 2024 20:58
  42. Peanut allergy is a common food allergy with potentially life-threatening implications. Early oral immunotherapy for peanut allergy (P-EOIT) has been shown to be effective and safe in research and specialty cl...

    Authors: Victoria Landry, Rachel Lewis, William Lewis, Lyndsey MacDonald, Beth Carson, Kavish Chandra, Jacqueline Fraser, Andrew J. Flewelling, Paul Atkinson and Chris Vaillancourt
    Citation: Allergy, Asthma & Clinical Immunology 2024 20:57
  43. Patients with asthma with an eosinophilic phenotype may be eligible for additional treatment options to improve disease control; however, the prevalence and frequency of eosinophil testing is unknown. This stu...

    Authors: Sameer Mathur, Thomas Corbridge, Elizabeth Packnett, Krutika Jariwala-Parikh and Arijita Deb
    Citation: Allergy, Asthma & Clinical Immunology 2024 20:56

The official journal of CSACI

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 2.6
    5-year Journal Impact Factor: 3.5
    Source Normalized Impact per Paper (SNIP): 0.904
    SCImago Journal Rank (SJR): 0.749

    Speed 2024
    Submission to first editorial decision (median days): 11
    Submission to acceptance (median days): 139

    Usage 2024
    Downloads: 1,301,911
    Altmetric mentions: 649